$PMCB ~ PharmaCyte Biotech, Inc. due diligence

New Post Public Reply Private Reply Replies (0) Message Board
Pistol Pete
$PMCB ~ PharmaCyte Biotech, Inc. due diligence report

$PMCB recent news/filings

## source: finance.yahoo.com

Wed, 29 Apr 2015 13:01:24 GMT ~ PHARMACYTE BIOTECH, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhi


read full: http://biz.yahoo.com/e/150429/pmcb8-k.html
*********************************************************

Tue, 28 Apr 2015 13:30:00 GMT ~ Unprecedented Diabetes Research Collaboration to Lead to Expedited PharmaCyte Biotech Clinical Trials

[PR Newswire] - BALTIMORE, Apr. 28, 2015 /PRNewswire/ -- Goldman Small Cap Research, a stock market research firm specializing in the small cap and microcap sectors, announced today that it has issued a new sponsored research article on PharmaCyte Biotech, Inc. (OTCQB – PMCB), a publicly traded, clinical stage biotechnology company focused on developing and preparing treatments for cancer and diabetes. In the update, analyst Rob Goldman discusses how current and future diabetes research collaboration should lead to expedited human clinical trials. "One of the untold stories behind PharmaCyte Biotech's success is that the formation and implementation of its International Diabetes Consortium has already resulted in unique and unprecedented collaboration on diabetes research which should lead to expedited clinical trials.

read full: http://finance.yahoo.com/news/unprecedented-d...00163.html
*********************************************************

Thu, 23 Apr 2015 13:20:00 GMT ~ PharmaCyte Biotech Awaits Pivotal U.S. Study Results Expected to Lead to Human Clinical Trials

[Marketwired] - PharmaCyte Biotech is not a big company by any means, but their lineup of treatments is certainly standing tall these days. The international biotech firm is already set to head into Phase 2b clinical ...

read full: http://finance.yahoo.com/news/pharmacyte-biot...00215.html
*********************************************************

Wed, 22 Apr 2015 13:30:00 GMT ~ PharmaCyte Biotech Moving Closer to Human Clinical Trials Around an Elite New Leadership Team

[PR Newswire] - BALTIMORE, Apr, 22, 2015 /PRNewswire/ -- Goldman Small Cap Research, a stock market research firm specializing in the small cap and microcap sectors, announced today that it has issued a new sponsored research article on PharmaCyte Biotech, Inc. (OTCQB – PMCB), a publicly traded, clinical stage biotechnology company focused on developing and preparing treatments for cancer and diabetes. In the update, analyst Rob Goldman discusses the Company's elite new leadership team and how they help set the stage for future human clinical trials for diabetes and cancer.

read full: http://finance.yahoo.com/news/pharmacyte-biot...00739.html
*********************************************************

Mon, 20 Apr 2015 16:49:47 GMT ~ PharmaCyte Biotech Finalizes International Diabetes Consortium to Cure Diabetes

[at noodls] - SILVER SPRING, Md., April 20, 2015 (GLOBE NEWSWIRE) - PharmaCyte Biotech, Inc. (PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes using its ...

read full: http://www.noodls.com/view/1183FD0A7098EC2561...AE65AECA06
*********************************************************

$PMCB charts

basic chart ## source: stockcharts.com



basic chart ## source: stockscores.com



big daily chart ## source: stockcharts.com



big weekly chart ## source: stockcharts.com


$PMCB company information

## source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/PMCB/company-info
Ticker: $PMCB
OTC Market Place: OTCQB
CIK code: 0001157075
Company name: PharmaCyte Biotech, Inc.
Company website: http://www.PharmaCyteBiotech.com
Incorporated In: NV, USA

Business Description: PharmaCyte Biotech is a clinical stage biotechnology company focused on developing and preparing to commercialize treatments for cancer and diabetes based upon a proprietary cellulose-based live cell encapsulation technology known as Cell-in-a-Box�. This unique and patented technology will be used as a platform upon which treatments for several types of cancer, including advanced, inoperable pancreatic cancer, and diabetes are being built. PharmaCyte Biotech's treatment for pancreatic cancer involves low doses of the well-known anticancer prodrug ifosfamide, together with encapsulated live cells, which convert ifosfamide into its active or \"cancer-killing\" form. These capsules are placed as close to the cancerous tumor as possible to enable the delivery of the highest levels of the cancer-killing drug at the source of the cancer. This \"targeted chemotherapy\" has proven remarkably effective in past clinical trials. PharmaCyte Biotech is also working towards improving the quality of life for patients with advanced pancreatic cancer and on treatments for other types of solid cancerous tumors. In addition, PharmaCyte Biotech is developing treatments for cancer based upon chemical constituents of the Cannabis plant, known as cannabinoids. In doing so, PharmaCyte Biotech is examining ways to exploit the benefits of Cell-in-a-Box� technology in optimizing the anticancer effectiveness of cannabinoids, while minimizing or outright eliminating the debilitating side effects usually associated with cancer treatments. This provides PharmaCyte Biotech the rare opportunity to develop ?green? approaches to fighting deadly diseases, such as cancer of the pancreas, brain and breast, which affect hundreds of thousands of individuals worldwide every year.Less >>


$PMCB share structure

## source: otcmarkets.com

Market Value: $105,457,429 a/o May 05, 2015
Shares Outstanding: 707,767,981 a/o Mar 13, 2015
Float: 529,206,849 a/o Aug 26, 2014
Authorized Shares: 1,490,000,000 a/o Aug 26, 2014
Par Value: 0.0001
$PMCB extra dd links

Company name: PharmaCyte Biotech, Inc.
Company website: http://www.PharmaCyteBiotech.com

## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/PMCB/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/PMCB/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=PMCB+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=PMCB+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=PMCB+Industry

## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/PMCB/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/PMCB/news - http://finance.yahoo.com/q/h?s=PMCB+Headlines

## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/PMCB/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/PMCB/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/PMCB/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/PMCB/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/PMCB/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/PMCB/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/PMCB/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/PMCB/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=PMCB+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/PMCB
DTCC (dtcc.com): http://search2.dtcc.com/?q=PharmaCyte+Biotech...ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&am...ech%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results...=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://www.Pharm...iotech.com
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://www.Phar...otech.com#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://www.Pharm...iotech.com

## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/PMCB/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/compa...yword/PMCB
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/PMCB/financials?...-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/PMCB/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/PMCB/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?actio...p;count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/PMCB/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/PMCB/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/PMCB/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/PMCB/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?...rch=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=PMCB
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/PMCB/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=PMCB+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=PMCB+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=PMCB
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=PMCB
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=PMCB+Cash+Flow&annual

## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/PMCB/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=PMCB+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/PMCB.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=PMCB
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/PMCB/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/PMCB/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/PMCB/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/PMCB/insider-transactions

## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/PMCB
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/PMCB
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/PMCB:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=PMCB
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/st...icker=PMCB


PharmaCyte Biotech Inc. (PMCB) Stock Research Links

PMCB Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Conscious Spark Debuts Alphimiya® To Break Revenue Barriers

Updated Category News Views 4

Unlocking Enterprise Potential With Neuroscience Pioneering a fresh avenue in business strategy, Conscious Spark LLC unveils its latest innovation, Alphimiya®, a framework that rewires the executive brain for greater financial scalability. We're talking about a dive into the autonomic nervous system here—why settle for spreadsheets when you can tweak brainwaves for...

Continue Reading
Recycled Plastics to Soar: Market Set for $117.9B in 2031

Updated Category News Views 1

Riding the Waves of Recycled Plastics Market Growth Well, let's dive straight in and shake up the shelves on this one. The recycled plastics market is cruising towards a staggering $117.9 billion by the year 2031, jumping from $76.6 billion in 2026. That's a solid 9% compound annual growth rate (CAGR) if Wissen Research’s numbers are anything to go by. Quite frankly,...

Continue Reading
SAGA Metals Strikes Potential with Wolverine Drilling Program

Updated Category News Views 3

Drilling for Treasure in Labrador's Rich Earth Hey, ever felt that gritty thrill in your bones? That's what I imagine SAGA Metals must be feeling right now. When you're out there punching holes into Mother Earth hoping to hit pay dirt, and every single one of those holes hits something juicy—trust me, that's like hitting the jackpot before even knowing the lottery...

Continue Reading
Valvoline™ Fuels Up for Brazil 2027 with FIFA Sponsorship

Updated Category News Views 4

Brazilians Set to Welcome Valvoline™ You wouldn't expect an oil company to hitch its wagon to soccer, but here we are, folks. Valvoline™ Global Operations has linked up with the FIFA Women's World Cup Brazil 2027™ as an Official Supporter. This isn't just a footnote—a sponsorship with potential traction, given the global stage of soccer. Sit back as I break it...

Continue Reading
Radware Dominates SPARK Matrix™ for Bot Management

Updated Category News Views 5

Why Radware Stands Out in Bot Management Radware has been making quite the splash in the tech world, now sitting pretty as the leader in QKS Group's SPARK Matrix™ for Bot Management in 2026. This isn't just some random pat on the back; it's a recognition of Radware's outstanding execution. Their innovative approach, especially in the realm of cloud application...

Continue Reading
Fresenius Revamps U.S. Kidney Care with multiFiltratePRO

Updated Category News Views 5

Fresenius Takes a Giant Leap in Kidney Care Fresenius Medical Care is breaking new ground in the U.S., marking a significant milestone with the introduction of the multiFiltratePRO System for critically ill patients battling acute kidney injury (AKI). This isn't some run-of-the-mill equipment upgrade. It's an evolution in how critical care teams manage continuous kidney...

Continue Reading
Epson's Robotics Innovation Takes Center Stage at ASSEMBLY

Updated Category News Views 3

No More Robots in the Background Walking into The ASSEMBLY Show 2026, you'd think robots had finally emerged from their hushed backstage roles and are now ready to claim their rightful place in the spotlight. Epson's leading the charge with their fresh AX6 collaborative robot, a machine that might just change the game for good. AX6 Cobot: The New Kid on the Block Epson's...

Continue Reading
CAR T-Cell Therapy Offers New Hope for SPS Patients

Updated Category News Views 4

Game-changing Developments in CAR T-Cell Therapy Leaping straight into the meat of it—our friends at the University of Colorado Anschutz are onto something big. They've wrapped up a study pushing the boundaries of CAR T-cell therapy, and let me tell you, it looks like a real game-changer for those battling the rare beast known as stiff person syndrome (SPS). Breaking...

Continue Reading
Doximity Lawsuit: Investors Face November Deadline

Updated Category News Views 1

Hard Knocks for Doximity Investors Alright, so this isn't the place I usually find myself at that hour, but we're living in wild times if you're clinging to Doximity (NYSE:DOCS) shares. Listen up, because those lawyers are chiming in and they ain't just whistling Dixie. If you bought into DOCS between August 2024 and May 2026 and watched your investment bleed red ink,...

Continue Reading
Highlight's Pulse Offers Real-Time Consumer Insights

Updated Category News Views 4

Highlight Introduces Pulse for Instant Insights Ever find yourself waiting forever for consumer feedback? Well, folks, Highlight's making sure those days are behind us with their new launch: Pulse. They've taken the conventional consumer testing model and flipped it on its head with Highlight Twins. Imagine getting the pulse of your audience in mere seconds, not the...

Continue Reading

Top 5 Most Recently Viewed Articles

Grayscale Predicts Bitcoin Surge Amid New Crypto Landscape

Updated Category News Views 104

Grayscale's Bold Prediction for Bitcoin in 2026 Grayscale has outlined a promising outlook suggesting that 2026 could herald significant changes for the cryptocurrency market. This transformation is expected to be fueled by an increasing macroeconomic demand for alternative assets, paired with much-anticipated regulatory clarity. Institutional Adoption and Market...

Continue Reading
Unpacking Today's Market Dip: Wayfair and Its Competitors

Updated Category News Views 162

Current Market Situation for Wayfair Inc. Wayfair Inc. shares have seen a decline in trading activity recently as the furniture industry faces significant challenges. The recent tariff probe on furniture imports announced by President Donald Trump has raised concerns among investors. Wayfair, identified by the stock ticker W, is notably impacted due to its reliance on...

Continue Reading
SpartanNash's Food Solutions Expo Unites Grocers and Suppliers

Updated Category News Views 177

SpartanNash Hosts Annual Food Solutions Expo for Grocers SpartanNash, a renowned food solutions company, recently orchestrated its much-anticipated annual Food Solutions Expo. This two-day event serves as a dynamic platform for networking among grocery industry leaders and attracted nearly 2,000 participants from around the country. The expo took place at the DeVos Place...

Continue Reading
Ryan Mueller of MLG Capital Honored as Multifamily Influencer

Updated Category News Views 210

Ryan Mueller Recognized as a Multifamily Influencer MLG Capital, a prominent name in private real estate investments, has announced that Ryan Mueller, the Principal and Senior Vice President, has earned recognition as a 2025 Influencer in Multifamily Real Estate by GlobeSt. This prestigious accolade highlights Ryan's exceptional contributions and leadership in the sphere...

Continue Reading
Global Ship Lease's Strong Q3 2024 Performance and Future Outlook

Updated Category News Views 94

Global Ship Lease Reports Impressive Third Quarter of 2024 Global Ship Lease, Inc. (NYSE: GSL), a key player in the containership ownership market, has recently revealed its unaudited financial results for the third quarter of 2024, reflecting strong operational performance and strategic positioning in an evolving maritime landscape. Quarterly Highlights: A Solid...

Continue Reading